Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
7.70
-0.12 (-1.53%)
At close: Apr 28, 2026, 4:00 PM EDT
7.70
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:10 PM EDT

Silence Therapeutics Stock Forecast

Stock Price Forecast

The 5 analysts with 12-month price forecasts for Silence Therapeutics stock have an average target of 42.6, with a low estimate of 3.00 and a high estimate of 75. The average target predicts an increase of 453.25% from the current stock price of 7.70.

Analyst Consensus: Buy
Target Low Average Median High
Price $3.00 $42.6 $35 $75
Change -61.04% +453.25% +354.55% +874.03%
* Price targets were last updated on Mar 13, 2026.

Analyst Ratings

The average analyst rating for Silence Therapeutics stock from 5 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Nov '25Dec '25Jan '26Feb '26Mar '26Apr '26
Strong Buy 333333
Buy 222211
Hold 000000
Sell 000000
Strong Sell 111111
Total 666655

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$75
Strong Buy Reiterates $75 +874.03% Mar 13, 2026
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$75
Strong Buy Reiterates $75 +874.03% Sep 16, 2025
Chardan Capital
Chardan Capital
Strong Buy
Maintains
$35
Strong Buy Maintains $35 +354.55% Aug 8, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$75
Strong Buy Reiterates $75 +874.03% Jun 13, 2025
Chardan Capital
Chardan Capital
Strong Buy
Maintains
$35
Strong Buy Maintains $35 +354.55% Jun 13, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
from 559.00K
Revenue Next Year
n/a
EPS This Year
n/a
from -1.88
EPS Next Year
n/a
Fiscal Year FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Period Ending Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025
Revenue
16.81M21.66M31.64M43.26M559.00K
Revenue Growth
124.73%28.82%46.12%36.71%-98.71%
EPS
-1.80-1.56-1.46-0.98-1.88
EPS Growth
-----
Forward PE
-----
No. Analysts -----
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue
High
Avg
Low

Revenue Growth

Revenue Growth
High
Avg
Low

EPS Forecast

EPS
High
Avg
Low

EPS Growth

EPS Growth
High
Avg
Low
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.